Evidence map›Paper›PMID 42136643›Full record

ArticleFrontiers in immunology2026

Research trends on autoimmune liver diseases and gut microbiota (1989-2025): a bibliometric and visualization analysis based on the web of science core collection database.

Ying Wan, Mengyao Zheng, Wen Fu, Huiling Zhu, Yuting Li, Huiying Lin, Jie Chen, Jianwei Li, Qiulan Mo, Wenlin Tai and 1 more

Abstract read
In one paragraph

Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Ying WanDepartment of Gastroenterology, The Second Affiliated Hospital of Kunming Medical University, Kunming, China.
Mengyao ZhengDepartment of Gastroenterology, The Second Affiliated Hospital of Kunming Medical University, Kunming, China.
Wen FuDepartment of Gastroenterology, The Second Affiliated Hospital of Kunming Medical University, Kunming, China.
Huiling ZhuDepartment of Gastroenterology, The Second Affiliated Hospital of Kunming Medical University, Kunming, China.
Yuting LiDepartment of Gastroenterology, The Second Affiliated Hospital of Kunming Medical University, Kunming, China.
Huiying LinDepartment of Gastroenterology, The Second Affiliated Hospital of Kunming Medical University, Kunming, China.
Jie ChenDepartment of Gastroenterology, The Second Affiliated Hospital of Kunming Medical University, Kunming, China.
Jianwei LiDepartment of Gastroenterology, The Second Affiliated Hospital of Kunming Medical University, Kunming, China.
Qiulan MoDepartment of Gastroenterology, The Second Affiliated Hospital of Kunming Medical University, Kunming, China.
Wenlin TaiLaboratory Science Department, The Second Affiliated Hospital of Kunming Medical University, Kunming, China.
Jinhui YangDepartment of Gastroenterology, The Second Affiliated Hospital of Kunming Medical University, Kunming, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Autoimmune liver diseases (AILD) encompass autoimmune hepatitis (AIH), primary biliary cholangitis (PBC), primary sclerosing cholangitis (PSC), and IgG4-related sclerosing cholangitis (IgG4-SC), with both incidence and prevalence showing an upward trend in recent years. Increasing evidence indicates that the onset and progression of AILD are inextricably linked to the gut microbiota. So far, no comprehensive and objective bibliometric study on AILD and gut microbiota has been conducted. This study retrieved literature from the Web of Science Core Collection (WoSCC) and Scopus database up to October 13, 2025, for analysis and validation respectively. VOSviewer, CiteSpace, R, Bibliometrix, SciExplorer, and WPS Office analysis tools were employed to systematically evaluate research trends, hot topics, and knowledge structures in the field. Our analysis indicates a growing research trend in AILD-gut microbiota interactions, involving 58 countries, 981 institutions, and 3,528 authors. Influential journals in this field include

Indexed as

Autoimmune DiseasesGastrointestinal MicrobiomeHepatitis, AutoimmuneLiver DiseasesAnimalsBibliometricsCholangitis, SclerosingDatabases, FactualHumansautoimmune hepatitisautoimmune liver diseasesbibliometricgut microbiotaprimary biliary cholangitisprimary sclerosingcholangitisscopus

Identifiers

PMID42136643
PMCPMC13167972

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.